treatment group:human umbilical cord derived mesenchymal stem cells (HU - MSCs)

3 trials

Sponsors

Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, Cell Biotherapy Center, Daping Hospital, The Third Military Medical University, Cell Biotherapy Center, Daping Hospital, Third Military Medical University

Conditions

severe sepsis or septic shocksystemic lupus erythematosustraumatic optic neuropathy

Phase 1

Effective and safety evaluation of human umbilical cord derived mesenchymal stem cells (hU-MSCs)in systemic lupus erythematosus

RecruitingChiCTR-OPC-15006322

Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqingsystemic lupus erythematosus

Start: 2015-06-01Updated: 2017-04-18

Phase 2

Effective and safety evaluation of optic nerve canal decompression of optic nerve canal by nasoscope with human umbilical cord derived mesenchymal stem cells (HU - MSCs) transplantation in traumatic optic neuropathy

RecruitingChiCTR-TRC-14005093

Cell Biotherapy Center, Daping Hospital, The Third Military Medical Universitytraumatic optic neuropathy

Start: 2014-09-01Updated: 2017-04-18

Effective and safety evaluation of human umbilical cord derived mesenchymal stem cells (HU - MSCs) in severe sepsis or septic shock

RecruitingChiCTR-TRC-14005094

Cell Biotherapy Center, Daping Hospital, Third Military Medical Universitysevere sepsis or septic shock

Start: 2014-10-01Updated: 2017-12-18